Clinical Trials
5 trialsNCT06702826 2024-11-25
Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases
Xiangya Hospital of Central South University
Phase 2 Recruiting
NCT04671459 2023-06-28
TaRRGET
Prof. Franciszek Lukaszczyk Memorial Oncology Center
Phase 2 Unknown
NCT03754530 2018-11-27
Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown
NCT01898962 2013-07-15
Definitive Therapy for Oligometastatic Solid Malignancies
Rocky Mountain Cancer Centers
Phase 2 Unknown
NCT00805636 2010-05-12
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Aposense Ltd.
Phase 2 Unknown